Equities

PainReform Ltd

PRFX:NAQ

PainReform Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.85
  • Today's Change-0.12 / -4.04%
  • Shares traded10.50k
  • 1 Year change-94.65%
  • Beta0.7221
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

  • Revenue in USD (TTM)0.00
  • Net income in USD-17.67m
  • Incorporated2007
  • Employees6.00
  • Location
    PainReform Ltd65 Yigal Alon St.TEL AVIV-YAFO 6744316IsraelISR
  • Phone+972 37177051
  • Fax+972 99542266
  • Websitehttps://painreform.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Evofem Biosciences Inc17.10m-11.02m983.22k37.00------0.0575-0.6139-0.61390.039-0.65910.91771.642.92462,108.10-42.60-211.64----80.84---46.42-1,031.550.0933------8.20--164.08---10.59--
Bespoke Extracts Inc1.08m-1.12m1.20m10.00------1.12-0.1089-0.10890.105-0.20942.9716.9923.47107,984.00-308.41------45.10---103.69--0.0462-27.50----22,933.72--63.98------
Nexien Biopharma Inc0.00-196.19k1.42m0.00---------0.0029-0.00290.00-0.00560.00-------1,453.26-1,542.27---------------1.26--------33.93------
Altamira Therapeutics Ltd59.60k-224.50k1.60m10.000.62710.1799--26.820.67880.67880.03372.370.008-0.19973.365,960.18-2.99-66.27-5.77-113.27150.61---376.67-25,125.900.4268--0.0634------89.86------
Mallinckrodt PLC1.96bn917.30m1.60m2.80k----0.00150.000820.1920.2179.8752.210.46411.684.83698,892.9021.76-12.4925.91-15.8533.7735.6846.88-44.381.83-0.01380.6286---2.53-10.31-83.00------
Procyon Corp4.98m-312.97k1.63m19.00--0.7512--0.3274-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
60 Degrees Pharmaceuticals Inc462.61k-8.39m1.68m3.00------3.62-9.19-9.190.38673.240.05580.78632.00154,203.30-95.99---123.36--10.73---1,719.15--4.91--0.0256---50.40--35.51------
cbdMD Inc20.64m-23.42m1.73m52.00--0.5845--0.084-18.95-18.957.850.80550.88172.0120.35396,856.90-82.98-38.59-112.36-41.5063.4363.80-94.12-87.980.5172-3.890.3128---31.77120.9163.64---4.95--
PainReform Ltd0.00-17.67m1.75m6.00---------167.66-167.660.00-14.120.00----0.00-309.43-55.47-650.22-68.20---------------------6.28------
SOHM Inc-100.00bn-100.00bn1.82m--------------------------------------------------------------
InVitro International716.89k6.22k1.82m16.00228.572.49--2.540.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Panacea Life Sciences Holdings Inc2.76m-7.67m2.08m40.00------0.7511-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.124.79--46.59--12.33------
Lotus Pharmaceuticals Inc70.79m1.72m2.16m233.000.01450.00020.55860.03050.05530.05532.563.580.632137.2717.85303,836.901.5522.841.7126.4035.1041.622.4519.930.442830.800.05160.0028.7131.70-12.2251.1170.48--
Scisparc Ltd0.00-6.96m2.54m3.00--7.05-----1.22-1.510.000.03440.00----0.00-92.51-69.39-152.41-111.07-------527.17----0.9371--113.73---97.61------
Data as of Nov 25 2024. Currency figures normalised to PainReform Ltd's reporting currency: US Dollar USD

Institutional shareholders

2.62%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 30 Sep 202425.99k1.17%
Two Sigma Securities LLCas of 30 Sep 202417.23k0.77%
HRT Financial LP (US)as of 30 Sep 202414.31k0.64%
Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2024768.000.03%
Virtu Americas LLCas of 30 Sep 20240.000.00%
Armistice Capital LLCas of 30 Sep 20240.000.00%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.